by Stacey Johnson | Aug 2, 2024
He’s back! The regenerative medicine (RM) field’s unofficial mascot – Deadpool – is back in theatres and all over media and social media due to what one must assume is a super(hero)-sized marketing budget. Although some may disagree on his status as a mascot, you...
by Stacey Johnson | Jul 26, 2024
An assassination attempt on former president Donald Trump and President Joe Biden removing himself from the race and endorsing Vice President Kamala Harris has meant the last two weeks have been filled with election news. We can be certain that the coverage won’t stop...
by Laya Kiani | Jul 18, 2024
In last week’s post, “The role and impact of IP rights on innovation and investment in RM,” I discussed the importance of intellectual property (IP) rights in regenerative medicine (RM), highlighting how they drive innovation and secure competitive advantages....
by Laya Kiani | Jul 11, 2024
Intellectual property (IP) rights in regenerative medicine (RM) are crucial for sparking innovation and staying ahead in a competitive market. Protecting inventions through patents and other IP rights encourages investment by giving inventors exclusive market rights....
by Peace Chukwu | Jul 4, 2024
Cancer remains the second leading cause of death worldwide. The Canadian Cancer Society estimates about 247,100 new cancer cases and 88,100 cancer deaths in Canada in 2024. Ten million deaths worldwide have been estimated to have been caused by cancer in 2020. This...
by Stacey Johnson | Jun 28, 2024
As June comes to an end, so does Pride Month in Canada. In 12 years of blogging for Signals, I realize I have never covered the topic of STEM (science, technology, engineering and mathematics) and Pride, although I have written about Equity, Diversity and Inclusion...
by Lyla El-Fayomi | Jun 18, 2024
“Regenerative medicine news under the microscope” is a monthly feature highlighting a selection of impactful research findings and headlines across the many subfields of regenerative medicine. Throughout the past month, I’ve spotted some notable trends emerging in the...
by Laine Bodnar | Jun 12, 2024
Have you wondered how many cell and gene therapies (CGTs) have been approved in Canada? So did I. To track the number down, I first turned to my trusty internet search engine with hopes that a list of Health Canada-approved CGTs would already exist online. Notably, it...
by Don Gibbons | May 28, 2024
Spinal cord injury (SCI) seemed like a logical first target for pluripotent stem cell therapy. In many cases a discrete lesion blocks the brain’s nerve signals from reaching the muscles or other tissues they are supposed to instruct. The solution: turn stem cells into...
Comments